The role of the cyclic GMP-inhibited cyclic AMP-specific phosphodiesterase (PDE3) in regulating clonal BRIN-BD11 insulin secreting cell survival

Cellular Signalling

Volumn 12, Issue 8, 2000, Pages 541-548

  Ahmad, Masroor ^a   Flatt, Peter R ^b   Furman, Brian L ^a   Pyne, Nigel J ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^b UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

Apoptosis; Cyclic AMP; Insulin secretion; P42 p44 mitogen activated protein kinase; Phosphodiesterases; Phosphoinositide 3 kinase

Indexed keywords

CYCLIC AMP; CYCLIC GMP; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHODIESTERASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL SURVIVAL; ENZYME ACTIVITY; INSULIN RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; 3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ANIMAL; APOPTOSIS; CELL SURVIVAL; CLONE CELLS; CULTURE MEDIA, SERUM-FREE; INSULIN; INSULIN-LIKE GROWTH FACTOR I; ISLETS OF LANGERHANS; MITOGEN-ACTIVATED PROTEIN KINASES; P42 MAP KINASE; RATS; SUPPORT, NON-U.S. GOV'T;

EID: 0034253197     PISSN: 08986568     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0898-6568(00)00093-0     Document Type: Article

References (26)

1. Webb S.J., Harrison D.J., Wylie A.H. Adv Pharmacol. 41:1998;1-34.
2. Ingelsson E., Saldeen J., Welsh N. Immunol Lett. 63:1998;125-129.
3. Koyama M., Wada R., Sakuraba H., Mizukama H., Yagihashi S. Am J Pathol. 153:1998;537-545.
4. Stassi G., De-Maria R., Trucco G., Rudert W., Testi R., Galluzzo A., Giordano C., Trucco M. Exp Med. 186:1997;1193-1200.
5. Dypbukt J.M., Ankacrona M., Burkitt M., Sjoholm A., Strom K., Orrentius S., Nicotera P. J Biol Chem. 269:1994;30553-30560.
6. Kaneto H., Fuji J., Seo H.G., Suzuki K., Matsuoka T.-A., Nakamura M., Yamasaki Y., Kamada T., Taniguchi N. Diabetes. 44:1995;733-738.
7. Kagimot S., Yamad Y., Kubota A., Ishida H., Seino Y. Diabetologia. 39:1996;A107.
8. Sanchez-Margalet V., Luca V.M., Solano F., Goberna R. Exp Cell Res. 209:1993;160-163.
9. Kaneto H., Fuji J., Myint T., Miyazawa N., Islam K.N., Kawasaki Y.et al. Biochem J. 320:1996;855-863.
10. Loweth A.C., Williams G.T., Scarpello J.H.B., Morgan N. Exp Cell Res. 229:1996;69-76.
11. Hoorens A., Van de Casteele M., Kloppel G., Pipeleers D. J Clin Invest. 98:1996;1568-1574.
12. Zhao Z.A., Zhao H., Teague T., Fujimoto W., Beavo J.A. Proc Natl Acad Sci USA. 94:1999;3223-3228.
13. Shafiee-Nick R., Pyne N.J., Furman B.L. Br J Pharmacol. 115:1995;1486-1492.
14. Ueki H., Mitsugi S., Kawashima Y., Motoyashika T., Morita T. Endocrinology. 138:1997;2784-2789.
15. Baixera E., Garcia-Lozano E., Martinez A.-C. Scan J Immunol. 43:1996;406-412.
16. Tortorella C., Piazzolla G., Speccavento F., Antonaci S. Mediators Inflamm. 7:1998;391-396.
17. Webster C.R., Anwer M.S. Hepatology. 5:1998;1324-1331.
18. Journot L., Villalba M., Bockaert J. Ann NY Acad Sci. 865:1998;100-110.
19. McClenaghan N.H., Barnett C.R., Ah-Sing E., Abdel-Wahab Y.H.A., O'Harte F., Yoon T.W., Swanston-Flatt S.K., Flatt P.R. Diabetes. 45:1996;1132-1140.
20. McClenaghan N.H., Flatt P.R. J Mol Med. 77:1999;235-243.
21. Parrizas M., Saltiel A.R., LeRoith D. J Biol Chem. 272:1997;154-161.
22. Ulrich A., Bell J.R., Chen E.Y., Herrera R., Petruzzelli L.M., Dull T.J.et al. Nature. 313:1996;756-760.
23. Ahmad M., Abdel-Wahib H.A., Tate R., Flatt P.R., Pyne N.J., Furman B.L. Br J Pharmacol. 129:2000;1228-1234.
24. Barford D. Trends Biochem Sci. 21:1996;407-412.
25. Fauman E.B., Saper M.A. Trends Biochem Sci. 21:1996;413-417.
26. Reed J. Adv Pharmacol. 41:1998;501-532.